Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$84.21
-1.5%
$82.41
$73.31
$120.30
$210.11B0.3710.27 million shs12.18 million shs
NIKE, Inc. stock logo
NKE
NIKE
$74.69
+0.5%
$75.19
$52.28
$90.62
$114.27B1.248.41 million shs7.47 million shs
Procter & Gamble Company (The) stock logo
PG
Procter & Gamble
$158.02
+0.0%
$156.40
$149.91
$180.43
$367.85B0.366.15 million shs6.51 million shs
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
+1.44%+0.24%+7.66%+9.02%-27.95%
NIKE, Inc. stock logo
NKE
NIKE
-3.94%-5.65%-0.43%+18.29%-10.84%
Procter & Gamble Company (The) stock logo
PG
Procter & Gamble
+0.46%+1.21%+4.78%-4.92%-7.98%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
4.9964 of 5 stars
3.24.05.04.23.01.73.8
NIKE, Inc. stock logo
NKE
NIKE
4.5944 of 5 stars
2.35.04.21.52.32.51.9
Procter & Gamble Company (The) stock logo
PG
Procter & Gamble
4.7951 of 5 stars
3.34.04.21.73.42.51.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
2.35
Hold$107.4427.59% Upside
NIKE, Inc. stock logo
NKE
NIKE
2.70
Moderate Buy$78.224.72% Upside
Procter & Gamble Company (The) stock logo
PG
Procter & Gamble
2.67
Moderate Buy$175.1210.82% Upside

Current Analyst Ratings Breakdown

Latest NKE, PG, and MRK Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/26/2025
NIKE, Inc. stock logo
NKE
NIKE
Zacks Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong Sell ➝ Hold
8/22/2025
NIKE, Inc. stock logo
NKE
NIKE
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$115.00
8/18/2025
NIKE, Inc. stock logo
NKE
NIKE
Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform
8/15/2025
Procter & Gamble Company (The) stock logo
PG
Procter & Gamble
BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$177.00
7/31/2025
Procter & Gamble Company (The) stock logo
PG
Procter & Gamble
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetEqual Weight ➝ Equal Weight$161.00 ➝ $164.00
7/30/2025
Procter & Gamble Company (The) stock logo
PG
Procter & Gamble
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetBuy ➝ Buy$180.00
7/30/2025
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$97.00 ➝ $90.00
7/30/2025
Procter & Gamble Company (The) stock logo
PG
Procter & Gamble
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$175.00 ➝ $173.00
7/28/2025
NIKE, Inc. stock logo
NKE
NIKE
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Overweight$64.00 ➝ $93.00
7/25/2025
Procter & Gamble Company (The) stock logo
PG
Procter & Gamble
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Neutral$178.00 ➝ $170.00
7/17/2025
Procter & Gamble Company (The) stock logo
PG
Procter & Gamble
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$186.00 ➝ $180.00
(Data available from 9/3/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$64.17B3.28$9.47 per share8.89$19.64 per share4.29
NIKE, Inc. stock logo
NKE
NIKE
$46.31B2.38$2.63 per share28.36$8.95 per share8.35
Procter & Gamble Company (The) stock logo
PG
Procter & Gamble
$84.28B4.39$8.42 per share18.76$21.99 per share7.19
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$17.12B$6.4912.988.510.8925.79%41.05%16.55%10/30/2025 (Estimated)
NIKE, Inc. stock logo
NKE
NIKE
$3.22B$2.1634.5831.922.816.95%23.33%8.57%9/30/2025 (Estimated)
Procter & Gamble Company (The) stock logo
PG
Procter & Gamble
$15.97B$6.5124.2721.534.1418.95%32.69%13.49%10/17/2025 (Estimated)

Latest NKE, PG, and MRK Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
9/30/2025Q1 2026
NIKE, Inc. stock logo
NKE
NIKE
$0.27N/AN/AN/A$10.96 billionN/A
7/29/2025Q2 2025
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$2.03$2.13+$0.10$1.76$15.92 billion$15.81 billion
7/29/2025Q4 2025
Procter & Gamble Company (The) stock logo
PG
Procter & Gamble
$1.42$1.48+$0.06$1.48$20.79 billion$20.89 billion
6/26/2025Q4 2025
NIKE, Inc. stock logo
NKE
NIKE
$0.12$0.14+$0.02$0.14$10.69 billion$11.10 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$3.243.85%N/A49.92%14 Years
NIKE, Inc. stock logo
NKE
NIKE
$1.602.14%N/A74.07%22 Years
Procter & Gamble Company (The) stock logo
PG
Procter & Gamble
$4.232.68%N/A64.98%70 Years

Latest NKE, PG, and MRK Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/22/2025
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
quarterly$0.813.97%9/15/20259/15/202510/7/2025
8/7/2025
NIKE, Inc. stock logo
NKE
NIKE
quarterly$0.402.15%9/2/20259/2/202510/1/2025
7/8/2025
Procter & Gamble Company (The) stock logo
PG
Procter & Gamble
quarterly$1.05682.68%7/18/20257/18/20258/15/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
0.69
1.42
1.17
NIKE, Inc. stock logo
NKE
NIKE
0.60
2.21
1.50
Procter & Gamble Company (The) stock logo
PG
Procter & Gamble
0.49
0.70
0.49

Institutional Ownership

CompanyInstitutional Ownership
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
76.07%
NIKE, Inc. stock logo
NKE
NIKE
64.25%
Procter & Gamble Company (The) stock logo
PG
Procter & Gamble
65.77%

Insider Ownership

CompanyInsider Ownership
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
0.09%
NIKE, Inc. stock logo
NKE
NIKE
0.80%
Procter & Gamble Company (The) stock logo
PG
Procter & Gamble
0.18%
CompanyEmployeesShares OutstandingFree FloatOptionable
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
75,0002.50 billion2.50 billionOptionable
NIKE, Inc. stock logo
NKE
NIKE
77,8001.48 billion1.47 billionOptionable
Procter & Gamble Company (The) stock logo
PG
Procter & Gamble
109,0002.34 billion2.34 billionOptionable

Recent News About These Companies

Procter & Gamble: Better Off Buying An ETF

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Merck & Co., Inc. stock logo

Merck & Co., Inc. NYSE:MRK

$84.21 -1.27 (-1.49%)
Closing price 03:59 PM Eastern
Extended Trading
$84.20 -0.01 (-0.02%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

NIKE stock logo

NIKE NYSE:NKE

$74.69 +0.40 (+0.54%)
Closing price 03:59 PM Eastern
Extended Trading
$74.61 -0.08 (-0.11%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NIKE, Inc., together with its subsidiaries, designs, develops, markets, and sells athletic footwear, apparel, equipment, accessories, and services worldwide. The company provides athletic and casual footwear, apparel, and accessories under the Jumpman trademark; and casual sneakers, apparel, and accessories under the Converse, Chuck Taylor, All Star, One Star, Star Chevron, and Jack Purcell trademarks. It also sells a line of performance equipment and accessories comprising bags, sport balls, socks, eyewear, timepieces, digital devices, bats, gloves, protective equipment, and other equipment for sports activities under the NIKE brand; and various plastic products to other manufacturers. In addition, the company markets apparel with licensed college and professional team, and league logos, as well as sells sports apparel; and licenses unaffiliated parties to manufacture and sell apparel, digital devices, and applications and other equipment for sports activities under NIKE-owned trademarks. It sells its products to footwear stores; sporting goods stores; athletic specialty stores; department stores; skate, tennis, and golf shops; and other retail accounts through NIKE-owned retail stores, digital platforms, independent distributors, licensees, and sales representatives. NIKE, Inc. was founded in 1964 and is headquartered in Beaverton, Oregon.

Procter & Gamble stock logo

Procter & Gamble NYSE:PG

$158.02 +0.03 (+0.02%)
Closing price 03:59 PM Eastern
Extended Trading
$158.32 +0.30 (+0.19%)
As of 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Procter & Gamble Co. engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances. The Health Care segment includes oral care products like toothbrushes, toothpaste, and personal health care such as gastrointestinal, rapid diagnostics, respiratory, and vitamins, minerals, and supplements. The Fabric and Home care segment consists of fabric enhancers, laundry additives and detergents, and air, dish, and surface care. The Baby, Feminine and Family Care segment sells baby wipes, diapers, and pants, adult incontinence, feminine care, paper towels, tissues, and toilet paper. The company was founded by William Procter and James Gamble in 1837 and is headquartered in Cincinnati, OH.